Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions

Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions Objective The aim was to determine whether progesterone (P4) or 17-alpha-hydroxyprogesterone caproate (17P) directly inhibit human uterine contractility in vitro and thereby clarify their mechanisms of action. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Obstetrics and Gynecology Wolters Kluwer Health

Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions

7 pages

Loading next page...
 
/lp/elsevier/progesterone-but-not-17-alpha-hydroxyprogesterone-caproate-inhibits-uWZ4B0whVJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2008 Mosby, Inc.
ISSN
0002-9378
DOI
10.1016/j.ajog.2008.06.085
pmid
18928984
Publisher site
See Article on Publisher Site

Abstract

Objective The aim was to determine whether progesterone (P4) or 17-alpha-hydroxyprogesterone caproate (17P) directly inhibit human uterine contractility in vitro and thereby clarify their mechanisms of action.

Journal

American Journal of Obstetrics and GynecologyWolters Kluwer Health

Published: Oct 1, 2008

References